Clinical Trial Update: A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A randomized SAD and MAD study assessing safety and tolerability of RPh201 in healthy volunteers and adults with Alzheimer's disease; completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Healthy Volunteers

Drugs mentioned

• RPh201

Snippet

Sponsor: Regenera Pharma Ltd | Conditions: Healthy Volunteers, Moderate to Severe Alzheimer Patients | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-23